Arvinas (ARVN) Receivables - Net (2017 - 2026)
Arvinas' (ARVN) quarterly Receivables - Net came in at $3.2 million in Q1 2026, down 28.89% year-on-year from $4.5 million in Q1 2025, and up 220.0% quarter-over-quarter from $1.0 million in Q4 2025.
Arvinas (ARVN) Receivables - Net (2017 - 2026) Analysis & Trends
Arvinas' Receivables - Net history runs 10 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- On a quarterly basis, Receivables - Net fell 28.89% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 28.89% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 55.13% from the prior year.
- Receivables - Net climbed to $3.2 million in Q1 2026 per ARVN's latest filing, from $1.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $20.3 million in Q3 2025 and bottomed at $1.0 million in Q4 2022.
- The 5-year median for Receivables - Net is $9.2 million (2023), against an average of $8.7 million.
- Across the five-year window, Receivables - Net tumbled 93.33% in 2022 and surged 840.0% in 2023, its largest moves.
- Year by year, Receivables - Net stood at $1.0 million in 2022, then jumped by 840.0% to $9.4 million in 2023, then sank by 39.36% to $5.7 million in 2024, then sank by 82.46% to $1.0 million in 2025, then surged by 220.0% to $3.2 million in 2026.
- Per Business Quant, the three latest ARVN Receivables - Net figures stand at $3.2 million (Q1 2026), $1.0 million (Q4 2025), and $20.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Arvinas | 512.64 Mn | -102.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.20 Mn |
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 20.30 Mn |
| Sep 30, 2025 | 20.30 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 8.80 Mn |
| Sep 30, 2024 | 8.80 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 9.40 Mn |
| Dec 31, 2023 | 9.40 Mn |